Drug Discovery World

MAY 1, 2024

DDW’s Megan Thomas speaks to industry experts and thought leaders about the potential for therapeutic antibodies in 2024. Artificial intelligence (AI) AI is on everyone’s minds as we head into 2024; of course, this is across not just the drug discovery spectrum but is particularly relevant to therapeutic antibodies.

FDA Approval 147

FDA Approval Therapies FDA Molecular Biology 147

Drug Discovery World

DECEMBER 26, 2023

We are excited to enter into this partnership with Shionogi, a company sharing the same patient centric values as Sobi and look forward to launching cefiderocol from 2024.” The Chan Lab at UT Southwestern will enhance PhenoScope’s tumour bank with spatial transcriptomic data and provide bioinformatic analytic expertise.

Small Molecule 130

Small Molecule Drugs Molecular Biology Bioinformatics 130

Elrig

APRIL 29, 2024

With a background in Bioinformatics and Computational Biology, she has a keen interest in using technology to solve problems in healthcare and medicine. Fascinated by the potential of AI in medical research, I transitioned to BenevolentAI in early 2023 as a Biology Project Leader.

Bioinformatics 59

Bioinformatics Molecular Biology Drugs Cell Based Assays 59